Product Images Orbactiv
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Orbactiv NDC 70842-140 by Melinta Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
orbactiv 01
orbactiv 02
Orbactiv* (oritavancin) is a medication for intravenous infusion only. It comes in a single-dose vial that contains 400 mg of oitavancin. The recommended dosage is 1,200 mg administered as a single dose by intravenous infusion over three hours. Each vial should be reconstituted with 40 mL of sterile water for injection, and the reconstituted solution should be further diluted in 1,000 mL 5% Dextrose Injection as per the prescribing information before intravenous infusion. The medication should not be diluted with Sodium Chloride Injection. The medication should be stored between 20°C-25°C and excursions are permitted to 15°C-30°C. Each package contains three 400 mg single-dose vials. Orbactiv* is marketed by Melinta Therapeutics, LLC, located in Lincolnshire, IL, USA.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.